Viewing Study NCT02426151


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-02 @ 9:13 AM
Study NCT ID: NCT02426151
Status: COMPLETED
Last Update Posted: 2016-03-18
First Post: 2015-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects
Sponsor: LG Life Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module